… network, its putative role in the metastatic process and its implications in response/resistance
to the current and/or new approaching drugs in the clinical management of breast cancer. …

… have been recognized as a new hallmark of breast cancer (BC). The function seems to be
… give guide to clinical treatment. In this review, we give new insights into clinical impacts and …

… the greatest effect on clinical management of patients with breast cancer, novel radiotracers
and … for patients with breast cancer. National Comprehensive Cancer Network guidelines for …

Purpose For patients with breast cancer (BC), the optimal time to initiation of adjuvant
chemotherapy (TTC) after definitive surgery is unknown. We evaluated the association between …

… , of paired samples of primary breast cancer and metastatic recurrence. … As the primary focus
of this review was the clinical impact of … Similarly, studies assessing bilateral breast cancer, …

… In conclusion, APOBEC3B mutagenesis is a major factor in breast cancer and many other
human malignancies and much additional basic, translational, and clinical work is needed to …

… Very few tumor markers have been recommended for routine clinical care of patients with
breast cancer [1]. A framework to determine the clinical utility of tumor markers is required. In a …

… The development of familial and sporadic breast cancer is … -q12-13) in sporadic breast cancer,
polymerase chain reaction (… A total of 137 breast cancer and 15 benign breast specimens …

… Thus, this data suggests that subtyping within TN will not have a clinical impact based on
prognosis-only since no group has such an outstanding outcome that would allow avoiding …

… To our knowledge, the present study is the first demonstrating a clinical impact of miR-29c
in patients with breast cancer. It is tempting to speculate that this may at least partly be owing …